EV/EBITDA Ratio: 44.70x

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 44.70x is 18% above its estimated 1-year average of 37.76x, around the middle of its estimated 1-year range (22.56x–55.33x).

As of 2026-10-06T15:35:57.987Z.

CAI EV/EBITDA Ratio Metrics

EV/EBITDA vs. estimated history

At 44.7, EV/EBITDA is near its estimated 1-year median — higher than 62% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Caris Life Sciences, Inc. (CAI)?

The EV/EBITDA ratio for CAI stock is 44.70x.

Is Caris Life Sciences, Inc.'s EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 44.70x is 18% above its estimated 1-year average of 37.76x, around the middle of its estimated 1-year range (22.56x–55.33x).

Related Metrics